Iron oxide-based multifunctional nanoparticulate systems for biomedical applications: A patent review (2008-present)

Expert Opinion on Therapeutic Patents

Volumn 25, Issue 6, 2015, Pages 691-709

  El Hammadi, Mazen M ^a,b   Arias, José L ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b DAMASCUS UNIVERSITY   (Syrian Arab Republic)

Author keywords

Drug delivery; Hyperthermia; Iron oxide nanoparticles; Magnetic properties; MRI; Multifunctional nanoparticles; Multimodal imaging; Surface coating; Theranosis

Indexed keywords

GOLD; IRON OXIDE; IRON OXIDE NANOPARTICLE; NANOPARTICLE; ORGANIC COMPOUND; POLYMER; SILICON DIOXIDE; UNCLASSIFIED DRUG; FERRIC ION; FERRIC OXIDE; MAGNETITE NANOPARTICLE;

ANTIBACTERIAL ACTIVITY; BIOMEDICINE; CELL LABELING; COLLOID; CRYSTAL STRUCTURE; DECOMPOSITION; DRUG DELIVERY SYSTEM; HYPERPHOSPHATEMIA; HYPERTHERMIA; MAGNETISM; MATERIAL COATING; MOLECULAR IMAGING; MOLECULAR STABILITY; MULTIMODAL IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATENT; REVIEW; SURFACE PROPERTY; ANIMAL; CHEMISTRY; CRYSTALLIZATION; DRUG DESIGN; DRUG STABILITY; HUMAN; MEDICINAL CHEMISTRY; PROCEDURES;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; CRYSTALLIZATION; DRUG DELIVERY SYSTEMS; DRUG DESIGN; DRUG STABILITY; FERRIC COMPOUNDS; HUMANS; MAGNETITE NANOPARTICLES; PATENTS AS TOPIC;

EID: 84930225147     PISSN: 13543776     EISSN: 17447674     Source Type: Journal    
DOI: 10.1517/13543776.2015.1028358     Document Type: Review

References (90)

1. Wang YX. Superparamagnetic iron oxide based MRI contrast agents: current status of clinical application. Quant Imaging Med Surg 2011;1:35-40
2. Arias JL. Advanced methodologies to formulate nanotheragnostic agents for combined drug delivery and imaging. Expert Opin Drug Deliv 2011;8:1589-608
3. Reddy LH, Arias JL, Nicolas J, Couvreur P. Magnetic nanoparticles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications. Chem Rev 2012;112:5818-78
4. Laurent S, Saei AA, Behzadi S, et al. Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges. Expert Opin Drug Deliv 2014;11:1449-70
5. Ling D, Hyeon T. Chemical design of biocompatible iron oxide nanoparticles for medical applications. Small 2013;9:1450-66
6. Gao J, Gu H, Xu B. Multifunctional magnetic nanoparticles: design, synthesis, and biomedical applications. Acc Chem Res 2009;42:1097-107
7. Jin R, Lin B, Li D, Ai H. Superparamagnetic iron oxide nanoparticles for MR imaging and therapy: design considerations and clinical applications. Curr Opin Pharmacol 2014;18:18-27
8. Murray AR, Kisin E, Inman A, et al. Oxidative stress and dermal toxicity of iron oxide nanoparticles in vitro. Cell Biochem Biophys 2013;67:461-76
9. Soenen SJ, De Cuyper M, De Smedt SC, Braeckmans K. Investigating the toxic effects of iron oxide nanoparticles. Methods Enzymol 2012;509:195-224
10. Gu L, Fang RH, Sailor MJ, Park JH. In vivo clearance and toxicity of monodisperse iron oxide nanocrystals. ACS Nano 2012;6:4947-54
11. Petters C, Irrsack E, Koch M, Dringen R. Uptake and metabolism of iron oxide nanoparticles in brain cells. Neurochem Res 2014;39:1648-60
12. Teja AS, Koh PY. Synthesis, properties, and applications of magnetic iron oxide nanoparticles. Prog Cryst Growth Ch 2009;55:22-45
13. Institute of Process Engineering, Chinese Academy of Science. Chen G, Shu C, Huizhou L. Temperature sensing parents block polymer/iron oxide magnetic nanocarrier, preparation method and application thereof. CN101219218; 2008
14. Board of Supervisors of Louisiana State University. Leuschner C, Kumar C, Hansel W, Hormes J. In vivo imaging and therapy with magnetic nanoparticle conjugates. US2009169478; 2009
15. National Cheng Kung University. Chen DH, Banerjee SS. Magnetic nanoparticles for targeted hydrophobic drug delivery and their production method and application. TW200946131; 2009
16. National Cheng Kung University. Chen DH, Banerjee SS. Cyclodextrin-coated magnetic nanoparticle and its production method and application. TW200946128; 2009
17. Yathindranath V, Hegmann T, Van Leirop J, Moore DF. Enhancing clot busting medication in stroke with directed drug convection using magnetic nano-particles. US2010055042; 2010
18. University of Central Florida Research Foundation, Inc. Perez JM, Santra S. Multimodal, multifunctional polymer coated nanoparticles. US8236284; 2012
19. Institute of Life Sciences. Sahoo SK, Dilnawaz F, Singh AS. Water dispersible glyceryl monooleate magnetic nanoparticle formulation. US2013302508; 2013
20. Knu-Industry Cooperation Foundation. Kim KS, Lee YS, Nguyen TD. Preparation method of iron oxide nano particle having core-shell structure using one-pot process and the hollow sphere using thereof. KR20130093392; 2013
21. Zhejiang University. Lu X, Rao Y, Hong D. Application of superparamagnetic iron oxide nanoparticle applied in transdermal drug delivery system. CN103182086; 2013
22. Shanghai Jiao Tong University. Wan A, Gui R, Li H, Jin H. Method for preparing drug carrier based on magnetic carbon quantum dot/chitosan composite microsphere. CN102973948; 2013
23. University of Louisville Research Foundation, Inc. Knipp RJ, Nantz MH. Nanoparticles for drug delivery. WO2014124329; 2014
24. The Trustees of Dartmouth College. Baker I, Kekalo K. Magnetic nanoparticles, composites, suspensions and colloids with high specific absorption rate (SAR). WO2014089464; 2014
25. Charite-Universitatsmedizin Berlin. Wagner S, Taupitz M, Schellenberger E, et al. Nanoparticulate phosphate adsorbent on the basis of maghemite or maghemite/magnetite, production and uses thereof. US2014248363; 2014
26. The Johns Hopkins University, Nanomaterials Technology Pte Ltd. Ivkov R, Goh YW, Ng MT, et al. A process for making iron oxide nanoparticle preparations for cancer hyperthermia. WO2014085651; 2014
27. Qiao R, Yanga C, Mingyuan Gao M. Superparamagnetic iron oxide nanoparticles: from preparations to in vivo MRI applications. J Mater Chem 2009;19:6274-93
28. Laurent S, Forge D, Port M, et al. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 2008;108:2064-110
29. ChangChun Institute of Applied Chemistry. Jilin Z, Guangyan H, Jiazuan N, Dehui S. Method for preparing monodisperse Fe3O4 magnetic nanoparticles. CN101538068; 2009
30. National Health Research Institutes. Yang CS, Lo LW, Tai LA. Drug release from thermosensitive liposomes by applying an alternative magnetic field. US20090004258; 2009
31. Korea Research Institute of Bioscience and Biotechnology. Chung BH, Lim YT, Kim JK. Gold nanocages containing magnetic nanoparticles. US2010228237; 2010
32. Kaohsiung Medical University. Wang LF, Chen GJ. Preparation of poly (ethylene glycol)-b-poly-("-caprolactone)-poly(acrylic acid) and its applications. TW201422240; 2014
33. Mahmoudi M, Shokrgozar MA. Super paramagnetic iron oxide nanoparticles with metallic coatings and a method of synthesizing the same. US2014234429; 2014
34. Mahmoudi M, Shokrgozar MA. Plasmonic stable fluorescence superparamagnetic iron oxide nanoparticles and a method of synthesizing the same. US2014234226; 2014
35. The National Center for Nanoscience and Technology-China. Ge GL, Tang Y, Chu LY. Hydrosol of ferroferric oxide nanoparticles and preparation method and application thereof. CN103723773; 2014
36. Ciobanu N. Biocompatible magnetic nano-clusters containing iron oxide respectively iron oxide-boron with primary use in magnetic drug targeting and boron neutron capture therapy. EP2277544; 2011
37. Civil Aviation University of China. Ying G, Yan L, Xiulin L, et al. Ultrasound wave auxiliary hydrothermal synthesis technique for magnetic magnetic iron oxide nano ultra-tiny grain. CN101172664; 2008
38. Hebei Medical University. Jing W, Wei W, Caiqin Y, et al. Hydrothermal synthesis process of magnetic ferroferric oxide nanometer ultrafine particles in non-N2 atomosphere. CN101885512; 2010
39. Seoul National University Ind. Foundation. Hyeon T, Piao Y, Kim J. Metal oxide hollow nanocapsule and a method for preparing the same. WO2008069561; 2008
40. Piao Y, Kim J, Na HB, et al. Wrap-bake-peel process for nanostructural transformation from beta-FeOOH nanorods to biocompatible iron oxide nanocapsules. Nat Mater 2008;7:242-7
41. IHI Corp. Eguchi H, Ishikawa Y. Medicine having magnetism, guiding system for medicine and magnetismdetecting system. JP2009196913; 2009
42. The Johns Hopkins University. Ivkov R, Liapi E. Formulation and methods for enhanced interventional image-guided therapy of cancer. US2012277517; 2012
43. Memorial Sloan-Kettering Cancer Center. Kaittanis C, Grimm J. Delivery of therapeutic compounds with iron oxide nanoparticles. WO2014047318; 2014
44. Nanjing University. Ding Y, Chen H, Xu J. Drug-loaded nanoparticle with nuclide imaging, fluorescence imaging and MRI functions, and preparation method and application thereof. CN102921022; 2013
45. Horák D, Syková E, Babic M, et al. Superparamagnetic nanoparticles based on iron oxides with modified surface, method of their preparation and application. US2009309597; 2009
46. The Trustees of Dartmouth College. Cunkelman BP, Tate JA, Petryk AA, et al. Biodegradable iron oxide nanoparticle gel for tumor bed therapy. WO2014121224; 2014
47. Xie J, Wang J, Niu G, et al. Human serum albumin coated iron oxide nanoparticles for efficient cell labeling. Chem Commun (Camb) 2010;46:433-5.
48. Kummitha CM, Malamas AS, Lu ZR. Albumin pre-coating enhances intracellular siRNA delivery of multifunctional amphiphile/siRNA nanoparticles. Int J Nanomedicine 2012;7:5205-14
49. Elzoghby AO, Samy WM, Elgindy NA. Albumin-based nanoparticles as potential controlled release drug delivery systems. J Control Release 2012;157:168-82
50. Kratz F. Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. J Control Release 2008;132:171-83
51. Universita Degli Studi Di Urbino Carlo Bo. Magnani M, Antonelli A. Delivery of contrasting agents for magnetic resonance imaging. US2010061937; 2010
52. Antonelli A, Sfara C, Manuali E, et al. Encapsulation of superparamagnetic nanoparticles into red blood cells as new carriers of MRI contrast agents. Nanomedicine (Lond) 2011;6:211-23
53. Arias JL, Reddy LH, Othman M, et al. Squalene based nanocomposites: a new platform for the design of multifunctional pharmaceutical theragnostics. ACS Nano 2011;5(2):1513-21
54. Donghua University. Chuanglong H, Xiao C, Jinwei H, et al. Preparation method of hollow mesoporous silica nanoparticles. CN102786061; 2012
55. Mahmoudi M, Shokrgozar MA. Multifunctional stable fluorescent magnetic nanoparticles. Chem Commun (Camb) 2012;48:3957-9
56. Liapi E, Wabler M, Gilson W, et al. Evaluation of multimodal imageable formulation for thermochemoembolization of liver cancer. Radiological Society of North America 2011 Scientific Assembly and Annual Meeting. Available from: http://archive. rsna.org/2011/11016234.html [Last accessed 4 November 2014]
57. National Chiao Tung University. Chen SY, Hu S, Liu DM. Method of forming a drug nanocarrier having a magnetic shell. US20090285885; 2009
58. Sungkyunkwan University. Lee DS, Guanghui G, Kim BS, Lee JH. MRI contrast agent using pH sensitive polymeric micelle and dds for diagnosis and therapy using thereof. KR20100030955; 2010
59. Gao G, Heo H, Lee J, Lee D. An acidic pH-triggered polymeric micelle for dualmodality MR and optical imaging. J Mater Chem 2010;20:5454-61
60. Lunov O, Syrovets T, Buchele B, et al. The effect of carboxydextran-coated superparamagnetic iron oxide nanoparticles on c-Jun N-terminal kinase-mediated apoptosis in human macrophages. Biomaterials 2010;31:5063-71
61. Wolf GL, Schmidt KF. Theranosis of macrophage-associated diseases with ultrasmall superparamagnetic iron oxide nanoparticles (USPIO). US2014249413; 2014
62. Yathindranath V, Hegmann T, van Lierop J, et al. Simultaneous magnetically directed drug convection and MR imaging. Nanotechnology 2009;20:405101
63. National Yang-Ming University. Liu TY. Nano-and micro-bubbles with ultrasound-triggered release and imaging functionalities. US2014212502; 2014
64. Banerjee SS, Chen DH. Cyclodextrin conjugated magnetic colloidal nanoparticles as a nanocarrier for targeted anticancer drug delivery. Nanotechnology 2008;19:265602
65. Hu SH, Chen SY, Liu DM, Hsiao CS. Core/single-crystal-shell nanospheres for controlled drug release via a magnetically triggered rupturing mechanism. Adv Mater 2008;20:2690-5
66. Meng J, Fan J, Galiana G, et al. LHRH-functionalized superparamagnetic iron oxide nanoparticles for breast cancer targeting and contrast enhancement in MRI. Mat Sci Eng C 2009;29:1467-79
67. Tai LA, Tsai PJ, Wang YC, et al. Thermosensitive liposomes entrapping iron oxide nanoparticles for controllable drug release. Nanotechnology 2009;20:135101
68. Chen S, Li Y, Guo C, et al. Temperature-responsive magnetite/PEOPPO-PEO block copolymer nanoparticles for controlled drug targeting delivery. Langmuir 2007;23:12669-76.
69. Rao YF, Chen W, Liang XG, et al. Epirubicin-loaded superparamagnetic iron-oxide nanoparticles for transdermal delivery: cancer therapy by circumventing the skin barrier. Small 2015;11:239-47.
70. Kim DH, Kim KN, Kim KM, Lee YK. Targeting to carcinoma cells with chitosan-and starch-coated magnetic nanoparticles for magnetic hyperthermia. J Biomed Mater Res A 2009;88:1-11
71. Cunkelman BP, Chen EY, Petryk AA, et al. Development of a biodegradable iron oxide nanoparticle gel for tumor bed therapy. Proc Soc Photo Opt Instrum Eng 2013;8584:858411
72. Li L, Jiang W, Luo K, et al. Superparamagnetic iron oxide nanoparticles as MRI contrast agents for non-invasive stem cell labeling and tracking. Theranostics 2013;3:595-615
73. Li XX, Li KA, Qin JB, et al. In vivo MRI tracking of iron oxide nanoparticlelabeled human mesenchymal stem cells in limb ischemia. Int J Nanomedicine 2013;8:1063-73
74. Green MD, Snoeck HW. Novel approaches for immune reconstitution and adaptive immune modeling with human pluripotent stem cells. BMC Med 2011;9:51
75. Moraes L, Vasconcelos-dos-Santos A, Santana FC, et al. Neuroprotective effects and magnetic resonance imaging of mesenchymal stem cells labeled with SPION in a rat model of Huntington's disease. Stem Cell Res 2012;9:143-55
76. Ruggiero A, Guenoun J, Smit H, et al. In vivo MRI mapping of iron oxidelabeled stem cells transplanted in the heart. Contrast Media Mol Imaging 2013;8:487-94
77. Daldrup-Link HE, Nejadnik H. MR imaging of stem cell transplants in arthritic joints. J Stem Cell Res Ther 2014;4:165
78. Zhao Y, Zhang Z, Wang J, et al. Abdominal hernia repair with a decellularized dermal scaffold seeded with autologous bone marrow-derived mesenchymal stem cells. Artif Organs 2012;36:247-55
79. Horák D, Babic M, Jendelová P, et al. Effect of different magnetic nanoparticle coatings on the efficiency of stem cell labeling. J Magn Magn Mater 2009;321:1539-47
80. Babic M, Horák D, Trchová M, et al. Poly(L-lysine)-modified iron oxide nanoparticles for stem cell labeling. Bioconjug Chem 2008;19:740-50
81. Babic M, Horák D, Jendelová P, et al. Poly(N, N-dimethylacrylamide)-coated maghemite nanoparticles for stem cell labeling. Bioconjug Chem 2009;20:283-94
82. Sponarová D, Horák D, Trchová M, et al. The use of oligoperoxide-coated magnetic nanoparticles to label stem cells. J Biomed Nanotechnol 2011;7:384-94
83. Ahrens ET, Bulte JW. Tracking immune cells in vivo using magnetic resonance imaging. Nat Rev Immunol 2013;13:755-63
84. Mahmoudi M, Serpooshan V. Silver-coated engineered magnetic nanoparticles are promising for the success in the fight against antibacterial resistance threat. ACS Nano 2012;6:2656-64
85. Takeda S, Mishima F, Fujimoto S, et al. Development of magnetically targeted drug delivery system using superconducting magnet. J Magn Magn Mater 2007;311:367-71
86. Levy M, Lagarde F, Maraloiu VA, et al. Degradability of superparamagnetic nanoparticles in a model of intracellular environment: follow-up of magnetic, structural and chemical properties. Nanotechnology 2010;21:395103
87. Lundqvist M, Stigler J, Cedervall T, et al. The evolution of the protein corona around nanoparticles: a test study. ACS Nano 2011;5:7503-9
88. Lartigue L, Wilhelm C, Servais J, et al. Nanomagnetic sensing of blood plasma protein interactions with iron oxide nanoparticles: impact on macrophage uptake. ACS Nano 2012;6:2665-78
89. Levy M, Luciani N, Alloyeau D, et al. Long term in vivo biotransformation of iron oxide nanoparticles. Biomaterials 2011;32:3988-99
90. Lartigue L, Alloyeau D, Kolosnjaj-Tabi J, et al. Biodegradation of iron oxide nanocubes: high-resolution in situ monitoring. ACS Nano 2013;7:3939-52